INTRODUCTION: The purpose of the study was to test and evaluate the Three Levels of Needs Questionnaire (3LNQ) as a method to clarify if help is needed and provided for 12 palliative problems in patients with chronic kidney disease stage 4 (CKD4).MATERIAL AND METHODS: A total of 33 patients from a consecutive sample of patients with CKD4 were given two questionnaires. The 3LNQ measures problem intensity and unmet needs for 12 palliative problems. An open question was added allowing the patients to describe additional symptoms not included in the 3LNQ. The EuroQol 5-Dimensional 3-Level Questionnaire was distributed in order to determine the patients' health-related quality of life.RESULTS: A total of 27 patients returned the two questionnair...
Context: There is little evidence on the symptoms experienced by those with advanced (Stage 5) chron...
Contains fulltext : 51818.pdf (publisher's version ) (Closed access)OBJECTIVE: Sho...
Background: Chronic kidney disease (CKD) is associated with a range of symptoms, even at early stage...
Context: End-stage kidney disease (ESKD) is characterized by high physical and psychological burden,...
Background Chronic kidney disease (CKD) is associated with a high symptom burden and reduced quality...
Background: Patient-reported outcome measures (PROMs) are becoming increasingly important in healthc...
Background Patient-reported outcome measures (PROMs) are becoming increasingly important in healthca...
Background There is increasing recognition of the clinical need for timely and coordinated supportiv...
Chronic kidney disease (CKD) is a growing global problem affecting around 10% of many countries' pop...
Background: Although evidence shows that patients with end stage renal disease (ESRD) experience a h...
Background Chronic kidney disease (CKD) is a growing global problem affecting around 10% of many cou...
Background: It is often believed that patients with advanced chronic kidney disease (CKD) stage 4-5 ...
Aims: To develop a specific renal module for use alongsidethe Sheffield Profile Assessment for Refer...
Background: Chronic Kidney Disease (CKD) is associated with a range of symptoms, even at early stage...
Background: Numbers of patients with stage 5 chronic kidney disease (CKD) managed conservatively (wi...
Context: There is little evidence on the symptoms experienced by those with advanced (Stage 5) chron...
Contains fulltext : 51818.pdf (publisher's version ) (Closed access)OBJECTIVE: Sho...
Background: Chronic kidney disease (CKD) is associated with a range of symptoms, even at early stage...
Context: End-stage kidney disease (ESKD) is characterized by high physical and psychological burden,...
Background Chronic kidney disease (CKD) is associated with a high symptom burden and reduced quality...
Background: Patient-reported outcome measures (PROMs) are becoming increasingly important in healthc...
Background Patient-reported outcome measures (PROMs) are becoming increasingly important in healthca...
Background There is increasing recognition of the clinical need for timely and coordinated supportiv...
Chronic kidney disease (CKD) is a growing global problem affecting around 10% of many countries' pop...
Background: Although evidence shows that patients with end stage renal disease (ESRD) experience a h...
Background Chronic kidney disease (CKD) is a growing global problem affecting around 10% of many cou...
Background: It is often believed that patients with advanced chronic kidney disease (CKD) stage 4-5 ...
Aims: To develop a specific renal module for use alongsidethe Sheffield Profile Assessment for Refer...
Background: Chronic Kidney Disease (CKD) is associated with a range of symptoms, even at early stage...
Background: Numbers of patients with stage 5 chronic kidney disease (CKD) managed conservatively (wi...
Context: There is little evidence on the symptoms experienced by those with advanced (Stage 5) chron...
Contains fulltext : 51818.pdf (publisher's version ) (Closed access)OBJECTIVE: Sho...
Background: Chronic kidney disease (CKD) is associated with a range of symptoms, even at early stage...